VRAX

Virax Biolabs Group Ltd

0.1625

+0.0032+2.01%

After Hours: 0.1693 +0.0068 +4.18%16:15 03/30 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.2485/0.1625

TODAY RANGE0.2006-0.2800

VOL231.49M

MARKET CAP1.57M

52 WEEK RANGE0.1521-1.340

AVG VOL (3M)225.05K

% TURNOVER3,118.40%

TURNOVER--

P/E (TTM)-0.1691

% RANGE48.86%

EPS(TTM)-1.2495

P/E(FORWARD)-0.5283

P/B0.2603

BVPS0.8118

DIVIDEND--

P/S140.87

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP1.49M

SHARES OUTSTANDING7.42M

NEXT EARNINGS--

FREE FLOAT7.07M

LOT SIZE1

EX-DATE12/18/2023

News

Press Releases

Financial Reports

Profile

Reuters·03/20 14:43
Virax Biolabs Group Ltd. COO and Director Nigel William McCracken files initial beneficial ownership statement
TipRanks·03/18 22:00
Virax Biolabs Shareholders Approve Reverse Split, New Charter and 2026 Equity Plan After Adjourned AGM
Reuters·03/18 21:09
Virax Biolabs Delays 2025 Annual Shareholder Meeting After Failing to Reach Quorum, Reschedules for March 18, 2026
Reuters·03/18 20:08
Virax Biolabs Group names director Evan Michael Norton in initial beneficial ownership filing
Reuters·03/18 20:08
Virax Biolabs CEO Foster James Alexander Cunliffe Files Initial Beneficial Ownership Statement
Reuters·03/18 20:07
Virax Biolabs Director Iain David Miller Files Initial Beneficial Ownership Statement
Reuters·03/18 20:07
Virax Biolabs Group Ltd. CFO Jason Davis files initial beneficial ownership statement
TipRanks·01/30 21:28
Virax Biolabs Sets March 11, 2026 AGM to Vote on Reverse Share Split and New Equity Plan
Dow Jones·01/09 17:42
Virax Biolabs Price Target Cut to $1.00/Share From $3.00 by HC Wainwright & Co.
TipRanks·01/09 17:26
Virax Biolabs price target lowered to $1 from $3 at H.C. Wainwright
TipRanks·01/09 17:25
Virax Biolabs: Clinical Progress in PAIS and Extended Cash Runway Support Reiterated Buy Rating Despite Lowered Price Target
TipRanks·12/18/2025 21:15
Virax Biolabs files to sell 25.875M ordinary shares for holders
TipRanks·12/04/2025 21:28
Virax Biolabs Secures $5 Million in Private Placement to Advance Immunology Research
Reuters·12/04/2025 21:15
Virax Biolabs Raises $5 Million in Private Placement Sale of Shares
NASDAQ·12/04/2025 11:26
Virax Biolabs Unveils $5 Million Private Placement

Same Industry

Name/Symbol

Change%

Price

Virax Biolabs Group Ltd

VRAX

+2.01%

0.1625

Regeneron Pharmaceuticals

REGN

-2.51%

737.71

GRDX

BIONTECH

BNTX

-2.04%

85.68

United Therapeutics Corp.

UTHR

-1.82%

522.83

Siga Technologie

SIGA

+6.85%

5.30

Vertex Pharmaceuticals Inc

VRTX

+2.33%

443.16

Moderna

MRNA

-2.68%

48.23

CRL

MEDP

Talphera Inc

TLPH

-4.03%

0.7415

CBPO

ICON PLC

ICLR

+3.59%

105.74

IQV

MOLN

PRAH

ARCT

Gilead Sciences Inc

GILD

+1.56%

136.34

Aptevo Therapeutics Inc

APVO

-7.26%

3.960

INCY

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.